menu search

Global payments delivers q4 results a smidge ahead of street expectations - reiterate strong buy

Global Payments Delivers Q4 Results A smidge Ahead Of Street Expectations - Reiterate Strong Buy...

February 15, 2022, 10:00 am

Global payments delivers q4 results a smidge ahead of street expectations - reiterate strong buy

Global Payments Delivers Q4 Results A smidge Ahead Of Street Expectations - Reiterate Strong Buy...

February 15, 2022, 10:00 am

China's biggest chipmaker smic posts record revenue despite u.s. sanctions

smiC, China's largest chipmaker, is seen as a key player in Beijing's ambitions to become more self-suf...

February 11, 2022, 8:40 am

China's biggest chipmaker smic posts record revenue despite u.s. sanctions

smiC, China's largest chipmaker, is seen as a key player in Beijing's ambitions to become more self-suf...

February 11, 2022, 8:40 am

China's biggest chipmaker smic posts record revenue despite u.s. sanctions

smiC, China's largest chipmaker, is seen as a key player in Beijing's ambitions to become more self-suf...

February 11, 2022, 8:40 am

Wex inc. (wex) ceo melissa smith on q4 2021 results - earnings call transcript

WEX Inc. (WEX) CEO Melissa smith on Q4 2021 Results - Earnings Call Transcript...

February 10, 2022, 4:44 pm

Wex inc. (wex) ceo melissa smith on q4 2021 results - earnings call transcript

WEX Inc. (WEX) CEO Melissa smith on Q4 2021 Results - Earnings Call Transcript...

February 10, 2022, 4:44 pm

Wex inc. (wex) ceo melissa smith on q4 2021 results - earnings call transcript

WEX Inc. (WEX) CEO Melissa smith on Q4 2021 Results - Earnings Call Transcript...

February 10, 2022, 4:44 pm

Preprint suggests, vir-gsk's covid-19 antibody can evade omicron sub-variant

In January, amid the omicron surge, WHO's expert panel recommended GlaxosmithKline Plc GSK / Vir Bi...

February 10, 2022, 3:09 pm

Preprint suggests, vir-gsk's covid-19 antibody can evade omicron sub-variant

In January, amid the omicron surge, WHO's expert panel recommended GlaxosmithKline Plc GSK / Vir Bi...

February 10, 2022, 3:09 pm

Preprint suggests, vir-gsk's covid-19 antibody can evade omicron sub-variant

In January, amid the omicron surge, WHO's expert panel recommended GlaxosmithKline Plc GSK / Vir Bi...

February 10, 2022, 3:09 pm

Thunderbird entertainment appoints industry veteran lana castleman as its new marketing and communications director

Thunderbird Entertainment Group Inc (TSX-V:TBRD, OTCQX:THBRF) announced that it has appointed Lana Castleman as the company's new director of marketin...

February 10, 2022, 11:38 am

Thunderbird entertainment appoints industry veteran lana castleman as its new marketing and communications director

Thunderbird Entertainment Group Inc (TSX-V:TBRD, OTCQX:THBRF) announced that it has appointed Lana Castleman as the company's new director of marketin...

February 10, 2022, 11:38 am

Thunderbird entertainment appoints industry veteran lana castleman as its new marketing and communications director

Thunderbird Entertainment Group Inc (TSX-V:TBRD, OTCQX:THBRF) announced that it has appointed Lana Castleman as the company's new director of marketin...

February 10, 2022, 11:38 am

Can value investors select glaxosmithkline (gsk) stock now?

Is GlaxosmithKline (GSK) a great pick from the value investor's perspective right now? Read on to know ...

February 10, 2022, 10:46 am

Can value investors select glaxosmithkline (gsk) stock now?

Is GlaxosmithKline (GSK) a great pick from the value investor's perspective right now? Read on to know ...

February 10, 2022, 10:46 am

Can value investors select glaxosmithkline (gsk) stock now?

Is GlaxosmithKline (GSK) a great pick from the value investor's perspective right now? Read on to know ...

February 10, 2022, 10:46 am

Curevac starts phase 1 trial for experimental flu shot developed with gsk

Shares of CureVac CVAC, +5.06% gained 2.6% in premarket trading on Thursday after the company said it began dosing participants in a Phase 1 clinical ...

February 10, 2022, 7:16 am

Curevac starts phase 1 trial for experimental flu shot developed with gsk

Shares of CureVac CVAC, +5.06% gained 2.6% in premarket trading on Thursday after the company said it began dosing participants in a Phase 1 clinical ...

February 10, 2022, 7:16 am

Curevac starts phase 1 trial for experimental flu shot developed with gsk

Shares of CureVac CVAC, +5.06% gained 2.6% in premarket trading on Thursday after the company said it began dosing participants in a Phase 1 clinical ...

February 10, 2022, 7:16 am


Search within

Pages Search Results: